Dr. Reddy’s faces securities class action lawsuit in US

30 Nov 2017 Evaluate

Dr. Reddy’s Laboratories has been served a securities class action lawsuit in the US for alleged violations of federal securities laws. The lawsuit filed at the District Court for New Jersey seeks damages to compensate the class of investors for a purported decline in the company’s share price allegedly caused by the misstatements or omissions. The company believes that the asserted claims are without merit and intends to vigorously defend itself against the allegations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.



Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×